Cyanocobalamin is given through intramuscular or subcutaneous injections
Data is largely limited to laboratory and preclinical models, with minimal validated human research available
Professor Jastreboffs research contributions include: Principal investigator for GLP3 phase 2 obesity trial demonstrating 24.2% weight loss Leadership in clinical research examining triple hormone receptor agonists Extensive investigations of incretin-based therapies for obesity and metabolic disease Pioneering work on combination approaches to weight management Studies examining neurobiological mechanisms underlying obesity pharmacotherapy Her work has helped establish GLP3 as one of the most promising next-generation obesity treatments in clinical development, contributing to the scientific foundation for multi-pathway metabolic interventions
Lindholst, C., Wynne, P., Marriott, P., Pedersen, S
CSF-cNs are highly likely to take a large amount of iron from CSF to generate ROS
If any unusual reactions occur, discontinue use and seek professional medical advice